These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32335508)

  • 1. One Aspect of Coronavirus disease (COVID-19) Outbreak in Iran: High Anxiety among MS Patients.
    Naser Moghadasi A
    Mult Scler Relat Disord; 2020 Jun; 41():102138. PubMed ID: 32335508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Level of Anxiety among Iranian Multiple Sclerosis Fellowships During the Outbreak of COVID-19.
    Naser Moghadasi A
    Arch Iran Med; 2020 Apr; 23(4):283. PubMed ID: 32271605
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (COVID-19) Pandemic.
    Salari M; Zali A; Ashrafi F; Etemadifar M; Sharma S; Hajizadeh N; Ashourizadeh H
    Mov Disord; 2020 Jul; 35(7):1095-1096. PubMed ID: 32395849
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak.
    Stojanov A; Malobabic M; Milosevic V; Stojanov J; Vojinovic S; Stanojevic G; Stevic M
    Mult Scler Relat Disord; 2020 Oct; 45():102407. PubMed ID: 32702641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic.
    Ghajarzadeh M; Mirmosayyeb O; Barzegar M; Nehzat N; Vaheb S; Shaygannejad V; Maghzi AH
    Mult Scler Relat Disord; 2020 Aug; 43():102222. PubMed ID: 32464586
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problems.
    Abdi M
    Infect Control Hosp Epidemiol; 2020 Jun; 41(6):754-755. PubMed ID: 32192541
    [No Abstract]   [Full Text] [Related]  

  • 7. B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.
    Safavi F; Nourbakhsh B; Azimi AR
    Mult Scler Relat Disord; 2020 Aug; 43():102195. PubMed ID: 32460086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum.
    Louapre C; Maillart E; Roux T; Pourcher V; Bussone G; Lubetzki C; Papeix C
    Rev Neurol (Paris); 2020 Jun; 176(6):523-525. PubMed ID: 32362357
    [No Abstract]   [Full Text] [Related]  

  • 9. The Coronavirus Disease 2019 (COVID-19) and Alcohol Use Disorders in Iran.
    Rostami M
    Am J Mens Health; 2020; 14(4):1557988320938610. PubMed ID: 32703079
    [No Abstract]   [Full Text] [Related]  

  • 10. The second worldwide wave of interest in coronavirus since the COVID-19 outbreaks in South Korea, Italy and Iran: A Google Trends study.
    Strzelecki A
    Brain Behav Immun; 2020 Aug; 88():950-951. PubMed ID: 32311493
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of anxiety in epilepsy during coronavirus disease (COVID-19) pandemic.
    Salari M; Etemadifar M; Gharagozli K; Etemad K; Ashrafi F; Ashourizadeh H
    Epilepsy Behav; 2020 Nov; 112():107442. PubMed ID: 32949966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the incidence of the COVID-19 hotspot in Iran - Implications for Travellers.
    Arab-Mazar Z; Sah R; Rabaan AA; Dhama K; Rodriguez-Morales AJ
    Travel Med Infect Dis; 2020; 34():101630. PubMed ID: 32184130
    [No Abstract]   [Full Text] [Related]  

  • 13. New Methanol Poisoning Outbreaks in Iran Following COVID-19 Pandemic.
    Delirrad M; Mohammadi AB
    Alcohol Alcohol; 2020 Jun; 55(4):347-348. PubMed ID: 32400874
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 Outbreak: An Overview on Dentistry.
    Spagnuolo G; De Vito D; Rengo S; Tatullo M
    Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32235685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety Severity Levels and Coping Strategies during the COVID-19 Pandemic among People Aged 15 Years and Above in Gonabad, Iran.
    Mohammadzadeh F; Delshad Noghabi A; Khosravan S; Bazeli J; Armanmehr V; Paykani T
    Arch Iran Med; 2020 Sep; 23(9):633-638. PubMed ID: 32979912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Effect on Foot & Ankle Surgery in Shiraz, South of Iran.
    Vosoughi AR; Borazjani R
    J Foot Ankle Surg; 2020; 59(5):887. PubMed ID: 32741548
    [No Abstract]   [Full Text] [Related]  

  • 17. The emotional impact of COVID-19 outbreak in amyotrophic lateral sclerosis patients: evaluation of depression, anxiety and interoceptive awareness.
    De Lucia N; Ausiello FP; Spisto M; Manganelli F; Salvatore E; Dubbioso R
    Neurol Sci; 2020 Sep; 41(9):2339-2341. PubMed ID: 32666406
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 in Iran: round 2.
    Venkatesan P
    Lancet Infect Dis; 2020 Jul; 20(7):784. PubMed ID: 32592672
    [No Abstract]   [Full Text] [Related]  

  • 19. Outbreak of COVID-19 in a nursing home in Madrid.
    Bouza E; Pérez-Granda MJ; Escribano P; Fernández-Del-Rey R; Pastor I; Moure Z; Catalán P; Alonso R; Muñoz P; Guinea J;
    J Infect; 2020 Oct; 81(4):647-679. PubMed ID: 32592704
    [No Abstract]   [Full Text] [Related]  

  • 20. Iran's success in controlling the COVID-19 pandemic.
    Mohammadzadeh N; Shahriary M; Nasri E
    Infect Control Hosp Epidemiol; 2020 Nov; 41(11):1359-1360. PubMed ID: 32321602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.